A few years ago we were involved in marketing a medical device product called Deflux which is a urethral bulking agent injected during a surgical procedure to help with Stress Urinary Incontinence. The procedure had the backing of a number of surgeons in the UK but it failed to be adopted on a widespread basis. One of the reasons for this was that procedures using Urogynaecological meshes (sometimes known as transvaginal meshes) were much more prevalent and it was very difficult to get surgeons to adopt a different procedure.
At the time, there were an increasing number of lawsuits in the USA where patients were allegedly experiencing ‘mesh break up’ but even that didn’t really help the give Deflux. Predictably the problems experienced in the USA have recently come to light in the UK leading to some powerful headlines in our media.
The vaginal mesh scandal is the ‘new thalidomide’ – so where is the outcry?
– The Independent
Vaginal mesh implants: Hundreds sue NHS over ‘barbaric’ treatment.
– BBC News
Why hundreds of women are suing the NHS over vaginal mesh surgery: ‘It felt like I had cut glass inside me’
– The Telegraph
A campaign group has been set up to raise awareness of the life changing risks of what is often referred to as a “simple” day case operation. For more information, please visit: https://slingthemesh.wordpress.com/
Default Blue is a Design and Marketing agency with a focus on Healthcare. We’ve worked with many clients in the Continence Care sector and we’re happy to talk about marketing products where elements of sensitivity and discretion are important.